Volume 3, Issue 4 (12-2013)                   JABS 2013, 3(4): 387-391 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Kalhori Z, Azadbakht M, Bazdar A, Zeinali H. Polycystic Ovary Induction in Mouse by Testosterone Enanthate. JABS 2013; 3 (4) :387-391
URL: http://jabs.fums.ac.ir/article-1-137-en.html
1- Razi Universuty
2- , azadbakhtm_tmu@yahoo.com
Abstract:   (14904 Views)
Background &Objective: Polycystic ovary is the most common cause of infertility in Women. Animal models are required for understanding the pathogenesis of polycystic ovary. The objective of this study then was to develop an animal model for inducing the polycystic ovaries using testosterone enanthate.
Materials & Methods: In this study, for inducing the polycystic ovary phenotype, female rats about12-14 days-old were injected daily with testosterone enanthate for 2 and 4 weeks (experiment groups: 1 and 2), while the control groups (1 and 2) were injected only with vehicle.The ovaries from both groups were fixed and then were used for histological studies.
Results: Testosterone enanthate treatment causes the histological changes in mouse ovary and significantly increased the percentage of preantral and cystic follicles and decreased the percentage of antral follicles in the experiment group, comparing with the control group (P<0.05).
Conclusion: It concluded that testosterone enanthate can induces polycystic ovary in mouse.
Full-Text [PDF 847 kb]   (6568 Downloads)    
Type of Study: Research | Subject: Gynecology & Obstetrics
Received: 2012/07/10 | Accepted: 2013/11/3 | Published: 2014/03/16

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Advanced Biomedical Sciences

Designed & Developed by: Yektaweb

Creative Commons License
This work is licensed under a Creative Commons — Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)